Toggle navigation image image
Toggle navigation logologo
image image
  • About Inflarx
    • Management
    • Board
    • Company History
    • Vision
  • R&D
    • About Complement
    • About C5A
    • Technology
    • Pipeline
    • Clinical Development
      • Hidradenitis Suppurativa
        • Shine Study FAQ
      • ANCA-Associated Vasculitis
      • Pyoderma Gangraenosum
      • COVID-19
    • Publications & Posters
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Share Information
    • Analyst Coverage
    • Corporate Governance
    • Annual/Extraordinary General Meetings
    • E-mail alerts
  • Career
    • Open Positions
      • Global Supply Manager (m/f/d) (up to 2)
      • Global Supply Coordinator, (m/f/d)
      • Qualified Person, (m/f/d)

Conference Call on Company Update and Q3 Financial Report

  • Home
  • Investors
  • Events & Presentations
  • Conference Call on Company Update and Q3 Financial Report

The Company will host a conference call to provide details on the study and a strategic update in conjunction with its quarterly results on 7 November at 8am EST / 2pm CET.

 

Dial-in details:

From the US: +1 929 477 0402
From the UK: +44 (0) 330 336 9127
From Europe: +49 (0) 69 2222 25577

Conference Code: 3567762

 

Please dial in 10 minutes before the call to register. The webcast presentation for the conference call can be accessed here

For replay of the conference call visit https://webcasts.eqs.com/inflarx20191107

 

Download Presentation

<< back to list

 image
Quick Links
  • Impressum
  • Privacy
  • Technology
  • Pipeline
  • News
  • Career
  • Disclaimer
  • Contact
  • Newsletter
  • Member area
Contact Jena

InflaRx N.V.
Winzerlaer Str. 2
07745 Jena

+49 (0)3641 508 180

info@inflarx.de

Contact Munich

InflaRx N.V.
Fraunhoferstraße 22
82152 Martinsried

+49 (0)89 414 189 78 00

info@inflarx.de

© Copyright 2017 All Rights Reserved.
  • Developed by Ementals